Healthy Clinical Trial - Rest Time on Gain Aerobic & Anaerobic Performance

Status Not yet recruiting

Clinical Trial Summary

Based on studies of high intensity interval training (HIIT) in the literature, higher gains in VO2max and performance are obtained in short periods of training time. However, different designs training configurations, for example, changing the time interval, could influence such gains on VO2max and aerobic performance. The aim of the study was to observe the possible influences of diferetes types of rest intervals in high intensity interval exercise protocol on VO2max, and the aerobic and anaerobic performances in 12 weeks of training.

Clinical Trial Description

12-week experiment will be conducted, with a total of 30 high intensity interval training (HIIT) sessions in cycle ergometer. Both the first and the last week will serve to stabilize the basic values and also repeated after training. So, every other day will be held: 1) risk stratification for coronary artery disease, anthropometric measurements, cardiopulmonary test maximum effort; 2) stabilization of cardiopulmonary test values, determining the aerobic dependent variables: VO2max, peak power - PP, occurrence of power VO2max - PVO2Máx, maximum heart rate - HRMax, as well as familiarization with the HIIT protocol; 3) anaerobic performance test of 30 seconds determining the anaerobic dependent variables: peak lactate - LA, anaerobic power peak - PP, average power - PM. After the dependent variables have established, the subjects will be randomly distributed among three groups: two experimental and one control, and subjected to 30 sessions of HIIT (all out)with 30 seconds of stimulation in cycle ergometer, differentiated only by the recovery time (60 seconds and 120 seconds). The control group had only one continuous aerobic exercise (50-55% VO2max) with an average time similar to other training. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)

Related Conditions & MeSH terms

Healthy

Clinical Trial Details

NCT number	NCT02642302
Study type	Interventional
Source	Universidade Federal do Rio de Janeiro
Contact	Sérgio E. Machado, PhD
Phone	55 21 991567006
Email	secm80@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	December 2015
Completion date	April 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06052553` - A Study of TopSpin360 Training Device	N/A
Completed	`NCT05511077` - Biomarkers of Oat Product Intake: The BiOAT Marker Study	N/A
Recruiting	`NCT04632485` - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed	`NCT05931237` - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults	N/A
Completed	`NCT04527718` - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers	Phase 1
Terminated	`NCT04556032` - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women	N/A
Completed	`NCT04998695` - Health Effects of Consuming Olive Pomace Oil	N/A
Completed	`NCT04065295` - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225	Phase 1
Completed	`NCT04107441` - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects	Phase 1
Completed	`NCT01442831` - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects	Phase 1
Terminated	`NCT05934942` - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood	Phase 1
Recruiting	`NCT05525845` - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI	N/A
Completed	`NCT05515328` - A Study in Healthy Men to Test How BI 685509 is Processed in the Body	Phase 1
Completed	`NCT05030857` - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects	Phase 1
Completed	`NCT04967157` - Cognitive Effects of Citicoline on Attention in Healthy Men and Women	N/A
Recruiting	`NCT04714294` - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers	Phase 1
Recruiting	`NCT04494269` - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls	Phase 1
Completed	`NCT04539756` - Writing Activities and Emotions	N/A
Recruiting	`NCT04098510` - Concentration of MitoQ in Human Skeletal Muscle	N/A
Completed	`NCT03308110` - Bioavailability and Food Effect Study of Two Formulations of PF-06650833	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Rest Time on Gain Aerobic and Anaerobic Performance — Performance

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms